主要股东
注:以下部分股东代表特定权益共同体,直接或间接持有上市公司股份
| 序号 | 股东名称 | 是否机构 | 持股数(股) | 持股比例 | 持股变动数(股) | 持股数变动比例 | 投票权比例 |
|---|---|---|---|---|---|---|---|
| 1 | 贝莱德集团公司 | 是 | 1271.06万 | 10.30% |
|
|
-- |
| 2 | 领航集团有限公司 | 是 | 1083.04万 | 8.80% |
|
|
-- |
内部人交易
| 日期 | 股东名称 | 变动股数(万股) | 交易后持股数量(万股) | 交易价格 | 是否直接持有 | 内部人类型 |
|---|---|---|---|---|---|---|
| 2025-12-19 | OLUKOTUN ADEOYE Y |
|
4.05 | 66.70 | 是 | -- |
| 2025-12-19 | OLUKOTUN ADEOYE Y |
|
3.44 | 68.04 | 是 | -- |
| 2025-12-19 | OLUKOTUN ADEOYE Y |
|
3.36 | 68.48 | 是 | -- |
| 2025-12-19 | Anzalone Christopher Richard |
|
382.80 | 66.67 | 是 | Chief Executive Officer |
| 2025-12-19 | Anzalone Christopher Richard |
|
381.98 | 68.01 | 是 | Chief Executive Officer |
| 2025-12-19 | Anzalone Christopher Richard |
|
381.85 | 68.48 | 是 | Chief Executive Officer |
| 2025-12-19 | Anzalone Christopher Richard |
|
380.85 | 68.33 | 是 | Chief Executive Officer |
| 2025-12-19 | Anzalone Christopher Richard |
|
380.59 | 68.85 | 是 | Chief Executive Officer |
| 2025-12-19 | Waddill William D. |
|
6.25 | 66.66 | 是 | -- |
| 2025-12-19 | Waddill William D. |
|
5.71 | 68.01 | 是 | -- |
| 2025-12-19 | Waddill William D. |
|
5.66 | 68.53 | 是 | -- |
| 2025-12-19 | Vakiener Victoria |
|
4.30 | 66.63 | 是 | -- |
| 2025-12-19 | Vakiener Victoria |
|
3.77 | 67.97 | 是 | -- |
| 2025-12-19 | Vakiener Victoria |
|
3.57 | 68.39 | 是 | -- |
| 2025-12-17 | Anzalone Christopher Richard |
|
387.07 | 63.55 | 是 | Chief Executive Officer |
| 2025-12-17 | Anzalone Christopher Richard |
|
383.49 | 64.51 | 是 | Chief Executive Officer |
| 2025-12-17 | Anzalone Christopher Richard |
|
383.39 | 65.53 | 是 | Chief Executive Officer |
| 2025-12-17 | Anzalone Christopher Richard |
|
383.20 | 66.30 | 是 | Chief Executive Officer |
| 2025-12-16 | Waddill William D. |
|
6.49 | 0.00 | 是 | -- |
| 2025-12-16 | INGRAM DOUGLAS S |
|
4.62 | 0.00 | 是 | -- |
| 2025-12-16 | PERRY MICHAEL S |
|
12.31 | 0.00 | 是 | -- |
| 2025-12-16 | Ferrari Mauro |
|
7.66 | 0.00 | 是 | -- |
| 2025-12-16 | Lu Hongbo |
|
5.50 | 0.00 | 是 | -- |
| 2025-12-16 | Vakiener Victoria |
|
4.58 | 0.00 | 是 | -- |
| 2025-12-16 | OLUKOTUN ADEOYE Y |
|
4.36 | 0.00 | 是 | -- |
| 2025-12-12 | Anzalone Christopher Richard |
|
410.13 | 0.00 | 是 | Chief Executive Officer |
| 2025-12-12 | Anzalone Christopher Richard |
|
400.07 | 68.67 | 是 | Chief Executive Officer |
| 2025-12-12 | Anzalone Christopher Richard |
|
397.94 | 69.28 | 是 | Chief Executive Officer |
| 2025-12-12 | Anzalone Christopher Richard |
|
397.13 | 69.96 | 是 | Chief Executive Officer |
| 2025-12-12 | Anzalone Christopher Richard |
|
396.28 | 60.51 | 是 | Chief Executive Officer |
| 2025-12-12 | Anzalone Christopher Richard |
|
395.19 | 61.25 | 是 | Chief Executive Officer |
| 2025-12-12 | Anzalone Christopher Richard |
|
393.78 | 62.12 | 是 | Chief Executive Officer |
| 2025-12-12 | Anzalone Christopher Richard |
|
392.93 | 62.94 | 是 | Chief Executive Officer |
| 2025-12-12 | Anzalone Christopher Richard |
|
392.26 | 64.29 | 是 | Chief Executive Officer |
| 2025-12-12 | Anzalone Christopher Richard |
|
392.16 | 64.96 | 是 | Chief Executive Officer |
| 2025-12-12 | Anzalone Christopher Richard |
|
392.03 | 65.77 | 是 | Chief Executive Officer |
| 2025-12-12 | Anzalone Christopher Richard |
|
392.02 | 66.77 | 是 | Chief Executive Officer |
| 2025-12-12 | Anzalone Christopher Richard |
|
391.70 | 67.87 | 是 | Chief Executive Officer |
| 2025-12-05 | PERRY MICHAEL S |
|
11.52 | 61.03 | 是 | -- |
| 2025-11-28 | Ferrari Mauro |
|
6.88 | 56.39 | 是 | -- |
| 2025-10-01 | Hamilton James C |
|
21.21 | 35.00 | 是 | Chief Medical Officer |
| 2025-09-12 | Hamilton James C |
|
23.21 | 30.00 | 是 | Chief Medical Officer |
| 2025-09-02 | Hamilton James C |
|
24.71 | 25.00 | 是 | Chief Medical Officer |
| 2025-08-13 | Hamilton James C |
|
27.15 | 20.00 | 是 | Chief Medical Officer |
| 2025-08-13 | Hamilton James C |
|
26.21 | 20.00 | 是 | Chief Medical Officer |
| 2025-04-09 | Anzalone Christopher Richard |
|
402.71 | 9.93 | 是 | Chief Executive Officer |
| 2025-04-09 | Anzalone Christopher Richard |
|
402.37 | 10.75 | 是 | Chief Executive Officer |
| 2025-04-09 | Anzalone Christopher Richard |
|
402.21 | 11.76 | 是 | Chief Executive Officer |
| 2025-04-09 | Anzalone Christopher Richard |
|
397.21 | 10.87 | 是 | Chief Executive Officer |
| 2025-04-09 | Anzalone Christopher Richard |
|
392.13 | 11.49 | 是 | Chief Executive Officer |
| 2025-03-13 | Anzalone Christopher Richard |
|
411.38 | 0.00 | 是 | Chief Executive Officer |
| 2025-03-13 | Anzalone Christopher Richard |
|
406.24 | 15.07 | 是 | Chief Executive Officer |
| 2025-03-03 | Anzalone Christopher Richard |
|
407.38 | 7.75 | 是 | Chief Executive Officer |
| 2025-03-03 | Anzalone Christopher Richard |
|
390.71 | 18.03 | 是 | Chief Executive Officer |
| 2025-03-03 | Anzalone Christopher Richard |
|
377.38 | 17.02 | 是 | Chief Executive Officer |
| 2025-03-03 | Anzalone Christopher Richard |
|
394.05 | 7.75 | 是 | Chief Executive Officer |
| 2025-02-07 | Anzalone Christopher Richard |
|
377.38 | 20.10 | 是 | Chief Executive Officer |
| 2025-02-06 | INGRAM DOUGLAS S |
|
3.84 | 20.09 | 是 | -- |
| 2025-01-23 | OLUKOTUN ADEOYE Y |
|
3.58 | 21.00 | 是 | -- |
| 2025-01-04 | Myszkowski Kenneth Allen |
|
50.06 | 0.00 | 是 | Chief Financial Officer |
| 2025-01-04 | Myszkowski Kenneth Allen |
|
48.28 | 19.68 | 是 | Chief Financial Officer |
| 2025-01-04 | Myszkowski Kenneth Allen |
|
47.34 | 20.10 | 是 | Chief Financial Officer |
| 2025-01-04 | Myszkowski Kenneth Allen |
|
46.54 | 19.70 | 是 | Chief Financial Officer |
| 2025-01-04 | Myszkowski Kenneth Allen |
|
45.54 | 19.69 | 是 | Chief Financial Officer |
| 2025-01-04 | O'Brien Patrick |
|
56.44 | 0.00 | 是 | COO and General Counsel |
| 2025-01-04 | O'Brien Patrick |
|
54.47 | 19.69 | 是 | COO and General Counsel |
| 2025-01-04 | O'Brien Patrick |
|
53.52 | 20.10 | 是 | COO and General Counsel |
| 2025-01-04 | O'Brien Patrick |
|
52.72 | 19.69 | 是 | COO and General Counsel |
| 2025-01-04 | Hamilton James C |
|
30.49 | 0.00 | 是 | Chief Discovery/Trans Medicine |
| 2025-01-04 | Hamilton James C |
|
28.31 | 19.68 | 是 | Chief Discovery/Trans Medicine |
| 2025-01-04 | Hamilton James C |
|
27.21 | 20.11 | 是 | Chief Discovery/Trans Medicine |
| 2025-01-02 | Anzalone Christopher Richard |
|
376.43 | 19.05 | 是 | Chief Executive Officer |
| 2024-12-27 | OLUKOTUN ADEOYE Y |
|
3.67 | 20.00 | 是 | -- |
| 2024-12-23 | Anzalone Christopher Richard |
|
377.58 | 19.59 | 是 | Chief Executive Officer |
| 2024-12-18 | OLUKOTUN ADEOYE Y |
|
3.96 | 22.99 | 是 | -- |
| 2024-12-18 | PERRY MICHAEL S |
|
13.15 | 22.99 | 是 | -- |
| 2024-12-18 | Ferrari Mauro |
|
7.75 | 22.99 | 是 | -- |
| 2024-12-18 | Waddill William D. |
|
5.71 | 22.99 | 是 | -- |
| 2024-12-18 | Anzalone Christopher Richard |
|
370.24 | 20.52 | 是 | Chief Executive Officer |
| 2024-12-18 | Anzalone Christopher Richard |
|
369.41 | 21.74 | 是 | Chief Executive Officer |
| 2024-12-18 | Anzalone Christopher Richard |
|
368.83 | 22.12 | 是 | Chief Executive Officer |
| 2024-12-18 | Anzalone Christopher Richard |
|
378.83 | 0.00 | 是 | Chief Executive Officer |
| 2024-12-18 | Vakiener Victoria |
|
3.79 | 22.99 | 是 | -- |
| 2024-12-18 | Lu Hongbo |
|
4.72 | 22.99 | 是 | -- |
| 2024-12-16 | GIVEN DOUGLAS B |
|
12.47 | 21.90 | 是 | -- |
| 2024-12-16 | GIVEN DOUGLAS B |
|
12.42 | 22.04 | 是 | -- |
| 2024-12-16 | Waddill William D. |
|
4.41 | 21.90 | 是 | -- |
| 2024-12-16 | Waddill William D. |
|
4.04 | 22.04 | 是 | -- |
| 2024-12-16 | Vakiener Victoria |
|
2.12 | 21.91 | 是 | -- |
| 2024-09-30 | Lu Hongbo |
|
3.41 | 28.00 | 是 | -- |
| 2024-09-30 | Lu Hongbo |
|
3.49 | 27.50 | 是 | -- |
| 2024-09-30 | Lu Hongbo |
|
3.51 | 27.34 | 是 | -- |
| 2024-09-30 | Lu Hongbo |
|
3.56 | 25.00 | 是 | -- |
| 2024-09-30 | Lu Hongbo |
|
3.61 | 22.00 | 是 | -- |
| 2024-09-30 | Lu Hongbo |
|
3.04 | 0.00 | 是 | -- |
| 2024-07-02 | Oliver Tracie |
|
12.71 | 25.28 | 是 | Chief Commercial Officer |
| 2024-05-02 | Vakiener Victoria |
|
3.02 | 23.31 | 是 | -- |
| 2024-04-01 | Hamilton James C |
|
20.49 | 28.03 | 是 | Chief Discovery/Trans Medicine |
| 2024-03-18 | Lu Hongbo |
|
3.17 | 27.49 | 是 | -- |
| 2024-03-18 | Lu Hongbo |
|
3.27 | 28.00 | 是 | -- |
| 2024-03-18 | Lu Hongbo |
|
3.37 | 27.50 | 是 | -- |
| 2024-03-06 | Myszkowski Kenneth Allen |
|
40.06 | 35.19 | 是 | Chief Financial Officer |
| 2024-01-31 | Anzalone Christopher Richard |
|
377.25 | 14.54 | 是 | Chief Executive Officer |
| 2024-01-31 | Anzalone Christopher Richard |
|
373.48 | 32.16 | 是 | Chief Executive Officer |
| 2024-01-31 | Anzalone Christopher Richard |
|
371.50 | 32.71 | 是 | Chief Executive Officer |
| 2024-01-12 | Hamilton James C |
|
21.46 | 36.47 | 是 | Chief Discovery/Trans Medicine |
| 2024-01-12 | Hamilton James C |
|
21.09 | 37.37 | 是 | Chief Discovery/Trans Medicine |
| 2024-01-11 | GIVEN DOUGLAS B |
|
13.08 | 37.76 | 是 | -- |
| 2024-01-11 | GIVEN DOUGLAS B |
|
12.97 | 38.55 | 是 | -- |
| 2024-01-11 | Waddill William D. |
|
4.92 | 37.81 | 是 | -- |
| 2024-01-11 | Waddill William D. |
|
4.79 | 38.59 | 是 | -- |
| 2024-01-11 | Ferrari Mauro |
|
6.18 | 37.80 | 是 | -- |
| 2024-01-11 | Ferrari Mauro |
|
6.08 | 38.63 | 是 | -- |
| 2024-01-11 | Vakiener Victoria |
|
3.31 | 37.87 | 是 | -- |
| 2024-01-11 | Vakiener Victoria |
|
3.20 | 38.84 | 是 | -- |
| 2024-01-04 | Myszkowski Kenneth Allen |
|
45.67 | 0.00 | 是 | Chief Financial Officer |
| 2024-01-04 | Myszkowski Kenneth Allen |
|
45.53 | 34.04 | 是 | Chief Financial Officer |
| 2024-01-04 | Myszkowski Kenneth Allen |
|
44.95 | 34.97 | 是 | Chief Financial Officer |
| 2024-01-04 | Myszkowski Kenneth Allen |
|
44.06 | 35.65 | 是 | Chief Financial Officer |
| 2024-01-04 | Oliver Tracie |
|
13.66 | 0.00 | 是 | Chief Commercial Officer |
| 2024-01-04 | San Martin Javier |
|
20.68 | 0.00 | 是 | Chief Medical Officer |
| 2024-01-04 | San Martin Javier |
|
20.60 | 34.11 | 是 | Chief Medical Officer |
| 2024-01-04 | San Martin Javier |
|
20.29 | 35.03 | 是 | Chief Medical Officer |
| 2024-01-04 | San Martin Javier |
|
19.85 | 35.64 | 是 | Chief Medical Officer |
| 2024-01-03 | O'Brien Patrick |
|
40.87 | 31.83 | 是 | COO and General Counsel |
| 2024-01-03 | O'Brien Patrick |
|
40.59 | 32.52 | 是 | COO and General Counsel |
| 2024-01-03 | O'Brien Patrick |
|
40.55 | 33.41 | 是 | COO and General Counsel |
| 2024-01-03 | O'Brien Patrick |
|
40.38 | 32.65 | 是 | COO and General Counsel |
| 2024-01-03 | O'Brien Patrick |
|
40.22 | 32.63 | 是 | COO and General Counsel |
| 2024-01-03 | O'Brien Patrick |
|
48.72 | 0.00 | 是 | COO and General Counsel |
| 2024-01-03 | O'Brien Patrick |
|
48.53 | 33.99 | 是 | COO and General Counsel |
| 2024-01-03 | O'Brien Patrick |
|
47.71 | 34.99 | 是 | COO and General Counsel |
| 2024-01-03 | O'Brien Patrick |
|
46.44 | 35.65 | 是 | COO and General Counsel |
| 2024-01-03 | Hamilton James C |
|
17.87 | 31.81 | 是 | Chief Discovery/Trans Medicine |
| 2024-01-03 | Hamilton James C |
|
17.64 | 32.52 | 是 | Chief Discovery/Trans Medicine |
| 2024-01-03 | Hamilton James C |
|
21.88 | 35.00 | 是 | Chief Discovery/Trans Medicine |
| 2024-01-03 | Hamilton James C |
|
17.59 | 33.30 | 是 | Chief Discovery/Trans Medicine |
| 2024-01-03 | Hamilton James C |
|
25.09 | 0.00 | 是 | Chief Discovery/Trans Medicine |
| 2024-01-03 | Hamilton James C |
|
24.91 | 34.00 | 是 | Chief Discovery/Trans Medicine |
| 2024-01-03 | Hamilton James C |
|
24.11 | 34.94 | 是 | Chief Discovery/Trans Medicine |
| 2024-01-03 | Hamilton James C |
|
22.88 | 35.65 | 是 | Chief Discovery/Trans Medicine |
| 2024-01-02 | Anzalone Christopher Richard |
|
372.04 | 30.74 | 是 | Chief Executive Officer |
| 2024-01-02 | Anzalone Christopher Richard |
|
371.50 | 31.25 | 是 | Chief Executive Officer |